AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2013
Apr 1, 2013
32566_dirs_2013-04-01_e3c4ea46-1966-4d6f-86ef-45af6b5489d0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2013-04-01
Reporting Person: Rogers Ronald S. (Exec VP Corp Communications)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-04-01 | Incentive Stock Option (right to buy) | $25.12 | A | 15920 | Acquired | 2021-04-01 | Common Stock (15920) | Direct |
| 2013-04-01 | Non-Qualified Stock Option (right to buy) | $25.12 | A | 34080 | Acquired | 2021-04-01 | Common Stock (34080) | Direct |
Footnotes
F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2